Relief Cardiovascular
Relief Cardiovascular is a company focused on pioneering innovative solutions for the management of heart failure. As part of the inQB8 Medical Technologies portfolio, the company is developing the Relief System, a transcatheter smart implant designed to monitor and modulate renal vein pressures. This novel approach aims to improve fluid management in heart failure patients, enhancing both safety and efficacy.
Leadership & Board
- Current Number of Employees
- 19
- Current LinkedIn Followers
- 3,005
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $12M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $12M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Company Momentum Positive
Relief Cardiovascular LinkedIn following is increasing, signaling rising market interest, but its workforce is shrinking indicating potential contraction.
Employee Trend
Relief Cardiovascular had 19 employees as of October 12, 2026. The number of employees increased by 1 (5.56%) week-over-week.
Social Trend
Relief Cardiovascular had 3,005 followers as of October 12, 2026. The number of followers increased by 13 (0.43%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 08, 2025 | Series A | $12.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Broadview Ventures | Series A |
| Advent Life Sciences | Series A |
| Pacific Health Investment | Series A |
| Heartwork Capital | Series A |
| an undisclosed multinational strategic | Series A |
Similar Companies
A snapshot of private companies similar to Relief Cardiovascular, helping you discover and navigate related company profiles.
Related News and Analysis
